Last Price
35.77
Today's Change
+0.27 (0.76%)
Day's Change
35.33 - 35.77
Trading Volume
980,900
A price target is an analyst's projection of a share's future price.
Average Target Price, Price Call and Upside/Downside here are derived from Price Targets in the past 6 months.
Last Price
35.47
Avg Target Price
34.60
Upside/Downside
-0.87 (2.45%)Price Call
0
SELL
2
HOLD
2
BUY
Date | Open Price | Target Price | Upside/Downside | Price Call | Firm | View | Action |
---|
A LOOK AT DIVIDEND PERFORMANCE BETWEEN PALM OIL & BANKS, Calvin Tan
https://sgx.i3investor.com/blogs/Jbhouseforsale/2023-07-10-story-h4959...
2023-07-10 19:57
SGX (SGD): TSH Resources (TSH) DBS BANK Appeared in Top 10 with 38 Million TSH RESOURCES Shares Speak Volume, Calvin Tan
https://sgx.i3investor.com/blogs/Jbhouseforsale/2024-04-26-story-h49624695-SGX_SGD_TSH_Resources_TSH_DBS_BANK_Appeared_in_Top_10_with_38_Million_TSH.jsp
2024-04-26 08:54
7. UOB Kay Hian Nominees (Asing) Sdn. Bhd.
Exempt AN for UOB Kay Hian Pte. Ltd.
46,410,358
IS IN TOP 7 OF TSH RESOURCES WITH 46.4 MILLION TSH RESOURCES SHARES
calvintaneng
55,758 posts
Posted by calvintaneng > 1 minute ago | Report Abuse
A LOOK AT TSH RESOURCES (9059) 5 YEARS FINANCIAL RESULTS SHOW IMPROVING FUNDAMENTAL WHILE PRICES FALLEN TO GOOD BARGAIN LEVELS, Calvin Tan
https://sgx.i3investor.com/web/blog/detail/Jbhouseforsale/2024-08-15-story-h49627738-A_LOOK_AT_TSH_RESOURCES_9059_5_YEARS_FINANCIAL_RESULTS_SHOW_IMPROVING_FUN
2024-08-15 05:18
UOB IS IN TOP 7 OF TSH WITH 46.4 MILLION TSH SHARES
TSH RESOURCES AUGUST 2024 RESULTS: A Look at its Latest Balance Sheet, Calvin Tan
https://klse.i3investor.com/web/blog/detail/www.eaglevisioninvest.com/2024-08-22-story-h-153359913-TSH_RESOURCES_AUGUST_2024_RESULTS_A_Look_at_its_Latest_Balance_Sheet_Ca
2 months ago
jack_ng
Price target reduced to $15.5 by Maybank Kim Eng. It is time to take profit?
"2Q12 results, due Aug 7, are likely to be softer QoQ, in our view. Some features that we expect include a) stable loan expansion, b) a normalization of trading income and c) QoQ NIM contraction. The stock has outperformed its peers YTD (+22% vs 20% for DBS, 12% for OCBC). However, valuations are no longer cheap, in our view, with the stock trading at a 2012 P/BV of 1.4x for an ROE of 11.5% vs 1.1x for DBS (10.8% ROE) and 1.4x for OCBC (12.2% ROE). Our TP of SGD15.50 (P/BV 1.1x) is maintained."
2012-07-18 10:48